Recurrent and metastatic clivus chordoma: systemic palliative therapy retards disease progression
Authors:
- Ellen GelpiEGEllen Gelpi
- Daniela PrayerDPDaniela Prayer
- Karin DieckmannKDKarin Dieckmann
- Christian MatulaCMChristian Matula
- Marco HasslerMHMarco Hassler
- Johannes A HainfellnerJHJohannes A Hainfellner
- Christine MarosiCMChristine Marosi
- 1 November 2005
- journal article
- case report
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 16 (10) , 1139-1143
Abstract
We report on a male patient with progressive and metastatic clivus chordoma treated over a period of 9 years by a multidisciplinary approach. Within the first 4 years, the patient underwent surgery four times. Thereafter, he received radiotherapy and subsequent chemotherapy. Stabilization of disease was achieved repeatedly for variable periods under local radiotherapy, systemic chemotherapy, immunomodulatory and anti-angiogenic therapy with isotretinoin and interferon-alpha, followed by thalidomide. Due to the occurrence of brain and lung metastases 8 years after initial diagnosis, liposomal doxorubicin was added to thalidomide. At the last follow-up control the patient had stable disease, with no progression of the intracranial tumor and regression of pulmonary metastases. He is in a good physical, psychological and neurological condition with a Karnofsky score of 80. Our observations show that multimodal therapy including a systemic palliative approach is associated with long quiescent intervals in recurrent chordoma and with regression of its metastases. Use of substances with high efficacy on tumor tissue and low toxicity, allowing long-term administration, seems promising in similar situations.Keywords
This publication has 19 references indexed in Scilit:
- Skull base and nonskull base chordomasCancer, 2003
- Repeat operations in the management of clival chordomas: palliative surgeryJournal of Clinical Neuroscience, 2003
- Comprehensive Review of Intracranial ChordomaRadioGraphics, 2003
- A multidisciplinary team approach to skull base chordomasJournal of Neurosurgery, 2001
- Chordoma: incidence and survival patterns in the United States, 1973–1995Cancer Causes & Control, 2001
- Potential Novel Uses of ThalidomideDrugs, 2000
- Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-α and retinoidsBritish Journal of Cancer, 1999
- Chondroid chordoma versus low-grade chondrosarcoma of the base of the skull: can immunohistochemistry resolve the controversy?Journal of Neuro-Oncology, 1994
- Chemotherapy for cranial base tumorsJournal of Neuro-Oncology, 1994
- Chordomas and cartilaginous tumors at the skull baseCancer, 1973